TLDR: The National University Health System (NUHS) in Singapore has secured $1.81 million in funding for a five-year research project, “AI-Powered Precision Prevention of Dementia (AI-PREVENT)”. Led by Associate Professor Christopher Chen, the initiative aims to develop an AI model that integrates genetic, lifestyle, and clinical data to identify high-risk individuals for early, personalized dementia interventions.
The National University Health System (NUHS) in Singapore has been awarded a significant grant of $1.81 million to spearhead an innovative research project focused on dementia prevention. This funding, provided by the National Medical Research Council (NMRC) under its Open Fund-Large Collaborative Grant (OF-LCG), will support a five-year endeavor titled “AI-Powered Precision Prevention of Dementia (AI-PREVENT)”.
The project is under the leadership of Associate Professor Christopher Chen, who is the Director of the Memory Ageing and Cognition Centre (MACC) at NUHS and also from the Department of Pharmacology at NUS Medicine. The core objective of AI-PREVENT is to harness the power of artificial intelligence to enhance the early detection of individuals at a heightened risk of developing dementia, thereby enabling timely and tailored interventions.
Associate Professor Chen emphasized the critical global challenge posed by dementia and the pressing need for effective preventive strategies. He stated, “Dementia is a major public health challenge, and early intervention is crucial. Our AI-PREVENT program aims to revolutionize dementia prevention by identifying at-risk individuals much earlier and offering personalised interventions.”
The research methodology will involve a substantial cohort of participants from Singapore. Comprehensive health assessments will be conducted, and participants will undergo long-term follow-up to gather extensive data. This rich dataset, encompassing genetic information, lifestyle factors, and various clinical assessments, will be used to train the sophisticated AI model. The AI’s role will be to discern subtle patterns and risk factors that might not be readily apparent through conventional diagnostic approaches.
The anticipated impact of the AI-PREVENT program on public health is considerable. By accurately identifying at-risk individuals, the program will facilitate targeted interventions. These interventions are envisioned to include a range of strategies such as lifestyle modifications, cognitive training programs, and potentially pharmacological treatments, all meticulously customized to each individual’s unique risk profile. The overarching goal is to either delay or entirely prevent the onset of dementia, ultimately enhancing the quality of life for Singapore’s aging population.
Also Read:
- Singapore Explores AI Agents to Revolutionize Public Services, Emphasizing Safe and Responsible Deployment
- San Jose Pioneers AI Grant Program to Tackle Maternal Health, Food Waste, and Satellite Data
Furthermore, the project is designed to foster robust collaboration among clinicians, scientists, and artificial intelligence specialists. This interdisciplinary approach is expected to solidify Singapore’s position as a frontrunner in the development and implementation of AI-driven healthcare solutions. The insights and findings generated from the AI-PREVENT program are slated for translation into practical clinical applications, establishing a new paradigm for dementia prevention not only in Singapore but potentially across the globe.
